Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3/5
Yunnan Botanee Bio-Technology (300957 CH)
Watchlist
Contact IR
59
Analysis
Consumer Staples
•
China
Yunnan Botanee Bio-Technology Group Co. LTD manufactures and sells skin care and cosmetics. The Company produces masks, toners, hand creams, and other cosmetics. Yunnan Botanee Bio-Technology Group also develops new biology technologies.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Mao Geping Cosmetics
•
17 Apr 2024 23:00
Mao Geping Cosmetics Pre-IPO Tearsheet
Mao Geping Cosmetics (1478187D CH) is looking to raise around US$300m in its upcoming Hong Kong IPO. The bookrunner on the deal is CICC.
Clarence Chu
Follow
655 Views
Share
bullish
•
Zhongji Innolight
•
27 Apr 2023 21:19
ChiNext/ChiNext50 Index Rebalance Preview: Outperformance Maintained
We forecast 10 changes for the Chinext and 5 for the Chinext50. Impact is not large but these are liquid stocks that are moving. The potential adds...
Brian Freitas
Follow
497 Views
Share
bearish
•
Shanghai Chicmax Cosmetic
•
10 Apr 2023 00:55
Shanghai Chicmax Cosmetic (2145.HK) - Start to Enter a Vicious Cycle
After Chicmax released the ugly 2022 results, it seems to have enter a vicious cycle. If Chicmax cannot transform into a visionary R&D driven...
Xinyao (Criss) Wang
Follow
378 Views
Share
bullish
•
Empyrean Technology
•
19 Mar 2023 21:48
ChiNext/ChiNext50 Index Rebalance Preview: Overlapping Stocks & Recent Outperformance
We forecast 10 changes to the ChiNext & 5 changes to the ChiNext50 in June. There are a few overlapping stocks & the potential adds have...
Brian Freitas
Follow
446 Views
Share
bearish
•
Giant Biogene
•
17 Mar 2023 00:55
Giant Biogene Holding (2367.HK) - The Situation May Not Be as Rosy as It Looks
After Giant Biogene has been added to Hong Kong Stock Connect, liquidity would improve a lot. But lower-than-expected market space, competition and...
Xinyao (Criss) Wang
Follow
545 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.3
x